AAAAAA

   
Results: 1-11 |
Results: 11
REPLACEMENT OF DIVALPROEX SODIUM WITH VALPROIC ACID NOT CLEAR-CUT - REPLY
Authors: CRANOR CW SAWYER WT CARSON SW EARLY JJ
Citation: Cw. Cranor et al., REPLACEMENT OF DIVALPROEX SODIUM WITH VALPROIC ACID NOT CLEAR-CUT - REPLY, American journal of health-system pharmacy, 55(10), 1998, pp. 1073-1073
QUALITY-OF-LIFE AND PREFERENCES FOR TREATMENT FOLLOWING SYSTEMIC ADJUVANT THERAPY FOR EARLY-STAGE BREAST-CANCER
Authors: LINDLEY C VASA S SAWYER WT WINER EP
Citation: C. Lindley et al., QUALITY-OF-LIFE AND PREFERENCES FOR TREATMENT FOLLOWING SYSTEMIC ADJUVANT THERAPY FOR EARLY-STAGE BREAST-CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1380-1387
CLINICAL AND ECONOMIC-IMPACT OF REPLACING DIVALPROEX SODIUM WITH VALPROIC ACID
Authors: CRANOR CW SAWYER WT CARSON SW EARLY JJ
Citation: Cw. Cranor et al., CLINICAL AND ECONOMIC-IMPACT OF REPLACING DIVALPROEX SODIUM WITH VALPROIC ACID, American journal of health-system pharmacy, 54(15), 1997, pp. 1716-1722
TASK-ANALYSIS OF HOME CARE PHARMACY
Authors: BEMUS AM LINDLEY CM SAWYER WT MCALLISTER JC
Citation: Am. Bemus et al., TASK-ANALYSIS OF HOME CARE PHARMACY, American journal of health-system pharmacy, 53(23), 1996, pp. 2831-2839
VANCOMYCIN SERUM CONCENTRATIONS IN PATIENTS WITH RENAL DYSFUNCTION - A COMPARISON OF FLUORESCENCE POLARIZATION IMMUNOASSAY AND THE ENZYME-MULTIPLIED IMMUNOASSAY TECHNIQUE
Authors: PECKMAN HJ DUPUIS RE SAWYER WT BROUWER KLR CROSS RE
Citation: Hj. Peckman et al., VANCOMYCIN SERUM CONCENTRATIONS IN PATIENTS WITH RENAL DYSFUNCTION - A COMPARISON OF FLUORESCENCE POLARIZATION IMMUNOASSAY AND THE ENZYME-MULTIPLIED IMMUNOASSAY TECHNIQUE, Therapeutic drug monitoring, 18(6), 1996, pp. 647-653
TASK-ANALYSIS OF AIR-FORCE PHARMACY PRACTICE
Authors: BARTHOLOMEW A SAWYER WT COATS L
Citation: A. Bartholomew et al., TASK-ANALYSIS OF AIR-FORCE PHARMACY PRACTICE, American journal of health-system pharmacy, 52(2), 1995, pp. 174-183
APPROPRIATE USE OF HEPARIN - EMPIRIC VS NOMOGRAM-BASED DOSING
Authors: GUNNARSSON PS SAWYER WT MONTAGUE D WILLIAMS ML DUPUIS RE CAIOLA SM
Citation: Ps. Gunnarsson et al., APPROPRIATE USE OF HEPARIN - EMPIRIC VS NOMOGRAM-BASED DOSING, Archives of internal medicine, 155(5), 1995, pp. 526-532
COAG EXPERT
Authors: ROBERTS HR SAWYER WT
Citation: Hr. Roberts et Wt. Sawyer, COAG EXPERT, Annals of internal medicine, 122(5), 1995, pp. 399-399
PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT FACTOR VIIA
Authors: LINDLEY CM SAWYER WT MACIK BG LUSHER J HARRISON JF BAIRDCOX K BIRCH K GLAZER S ROBERTS HR
Citation: Cm. Lindley et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT FACTOR VIIA, Clinical pharmacology and therapeutics, 55(6), 1994, pp. 638-648
SAFETY AND INITIAL CLINICAL EFFICACY OF 3 DOSE LEVELS OF RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) - RESULTS OF A PHASE-I STUDY
Authors: MACIK BG LINDLEY CM LUSHER J SAWYER WT BLOOM AL HARRISON JF BAIRDCOX K BIRCH K GLAZER S ROBERTS HR
Citation: Bg. Macik et al., SAFETY AND INITIAL CLINICAL EFFICACY OF 3 DOSE LEVELS OF RECOMBINANT ACTIVATED FACTOR-VII (RFVIIA) - RESULTS OF A PHASE-I STUDY, Blood coagulation & fibrinolysis, 4(4), 1993, pp. 521-527
RELATION BETWEEN FACTOR-VIIA COAGULANT ACTIVITY AND PT AND BETWEEN FACTOR-VIIA COAGULANT ACTIVITY AND APTT IN HUMAN PLASMA
Authors: JOHANSEN L BUCHER D HANSEN LL KASTBERG H LINDLEY C MADSEN P SAWYER WT
Citation: L. Johansen et al., RELATION BETWEEN FACTOR-VIIA COAGULANT ACTIVITY AND PT AND BETWEEN FACTOR-VIIA COAGULANT ACTIVITY AND APTT IN HUMAN PLASMA, Thrombosis and haemostasis, 69(6), 1993, pp. 1125-1125
Risultati: 1-11 |